← Back to Search

Bone Graft

Test Group for Bone Grafting

N/A
Recruiting
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Flapless extraction possible
The tooth to be extracted must be bordered by two teeth
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

"This trial is comparing a new material for preserving the jawbone after a tooth extraction to a material that is already widely used and studied. They will be looking at the size of the jawbone after the

Who is the study for?
This trial is for individuals needing alveolar ridge preservation after tooth extraction. Specific eligibility criteria are not provided, so it's best to contact the study organizers for detailed requirements.Check my eligibility
What is being tested?
The study aims to compare a new bone grafting material with a well-established one in terms of effectiveness in preserving the alveolar ridge dimensions and tissue health following tooth extractions.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort, swelling, infection at the graft site, or rejection of the graft material.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My tooth can be removed without cutting the gums.
Select...
The tooth I need removed is between two other teeth.
Select...
I have enough gum tissue (2mm or more) before tooth removal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
changes in horizontal dimensions of the alveolar ridge
changes in vertical dimensions of the alveolar ridge
Secondary outcome measures
vital bone percentage
Other outcome measures
# of cigarettes and its influence on the ridge dimension
oral hygiene using the plaque index and its influence on the ridge dimension
the position of extraction site (maxilla vs. mandible) and its influence on the ridge dimension
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Test GroupExperimental Treatment1 Intervention
This group will receive the grafting material that is a combination of DFDBA + DBBM + collagen matrix seal during the alveolar ridge preservation procedure.
Group II: Control GroupActive Control1 Intervention
This group will receive the grafting material that is a Tutoplast® processed mineralized particulate allograft + collagen matrix seal during the alveolar ridge preservation procedure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alveolar ridge preservation
2019
N/A
~120

Find a Location

Who is running the clinical trial?

ZimVieIndustry Sponsor
24 Previous Clinical Trials
2,229 Total Patients Enrolled
Nova Southeastern UniversityLead Sponsor
89 Previous Clinical Trials
11,611 Total Patients Enrolled
Geistlich Pharma AGIndustry Sponsor
41 Previous Clinical Trials
2,046 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enroll participants for this particular trial?

"Indeed, as per the details on clinicaltrials.gov, this trial is actively seeking participants. Originally listed on January 26th, 2024, it was last revised on February 16th of the same year. The recruitment target stands at 30 patients across a single site."

Answered by AI

What is the current number of participants being recruited for this research study?

"Indeed, the details on clinicaltrials.gov show that this investigation is actively seeking eligible participants. Originally uploaded on January 26th, 2024, and last revised on February 16th, 2024, the trial aims to recruit a total of 30 individuals from one designated site."

Answered by AI

What are the potential risks associated with participation in the experimental group for individuals?

"According to our evaluation at Power, the safety rating for Test Group is 3 due to its Phase 4 status, indicating regulatory approval."

Answered by AI

Who else is applying?

What site did they apply to?
Nova Southeastern University
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

~20 spots leftby Jun 2025